Latest China Market News

Aumake Limited has obtained a Hong Kong pharmaceutical wholesale licence, enabling it to launch up to five online over-the-counter medicine stores targeting Chinese consumers. This strategic move positions the company to tap into China’s rapidly expanding OTC market.

Treasury Wine Estates moderates its first-half fiscal 2026 outlook due to softer US and China markets, unveiling a major transformation program targeting $100 million in annual cost savings starting next year.

Treasury Wine Estates moderates growth forecasts due to softening demand in key US and China markets, unveiling a major transformation program and cost-saving measures to safeguard brand strength and profitability.

Merino & Co. has secured a significant new order from its Shanghai distribution partner, reinforcing its expanding footprint in China’s luxury apparel market and validating its strategic growth plans.

RooLife Group's RLG Coffee brand has rapidly scaled to over A$1 million in sales in China just months after launch, supported by a substantial A$64 million supply agreement.

Nufarm Limited posted a $165.3 million statutory loss for FY25, driven by significant restructuring charges and omega-3 price declines, while announcing a CEO transition effective January 2026.

Merino & Co. has secured a significant distribution agreement with a Shanghai-based omni-channel partner, committing to annual sales of approximately A$1.5 million and expanding its footprint in China’s luxury fashion market.

Merino & Co. initiates a new chapter with leadership changes and a strategic partnership to enter China’s premium apparel market, while investing heavily in growth during Q1 FY26.

Nova Eye Medical reported a robust 32% increase in global sales excluding China for Q1 FY26 and secured regulatory approval for its iTrack™ Advance device in China, setting the stage for expanded market penetration.

CurveBeam AI reports a 33% increase in Q1 FY26 purchase orders, secures A$6.5 million in new funding, and finalizes a strategic joint venture for China distribution and manufacturing rights.

Fluence Corporation reported a robust 72.9% revenue increase year-to-date Q3 2025, fueled by the Ivory Coast Addendum project, while maintaining its full-year guidance despite some margin pressures.

CurveBeam AI has inked a decade-long exclusive partnership with a major Chinese medical device joint venture, unlocking rapid market entry and a $10 million capital boost to expand its weight bearing CT and AI solutions across Greater China.